Skip to main content
. 2019 Dec 3;11(12):1927. doi: 10.3390/cancers11121927

Figure 4.

Figure 4

TMS-TMF-4f reduces IL-6-mediated STAT3 activation in human cervical cancer cells. After pretreatment with TMS-TMF-4f for 1 h, cells were stimulated with IL-6 (10 ng/mL) for 5 min, and STAT3 activation was determined by (a) immunofluorescence and (b) Western blot analysis. The relative optical density ratio was determined using a densitometric analysis program (Bio-Rad Quantity One® Software, version 4.6.3 (Basic)), normalized to the internal control. Data are presented as the mean ± SD of three independent experiments. *** p < 0.001 vs. the control group. ### p < 0.001 vs. the TMS-TMF-4f-treated group.